ghada_galal

Ghada Galal

Professor - Head of Tropical Medicine and Gastroenterology Department

Faculty of medicine

Address: Sohag, Egypt

5

Like

Publications Which contain the keyword: CD34


2020-09-03 20:18:47 Keywords Urothelial carcioma, CD34, SCC,
The Value of CD34 Expression in  Squamous Cell Carcinoma and Urothelial Carcinoma of the Urinary Bladder
Background: Angiogenesis is important in the development of solid tumors. A variety of markers for identification of microvessels in histological sections are available, cluster of differentiation 34 (CD34) is one of the most commonly used factors. Aims: To evaluate the expression of CD34 in invasive squamous cell carcinoma (SCC) and urothelial carcinoma (UC) of the urinary bladder and correlation of ... Read more

2018-10-22 09:31:28 Keywords HCV, , CD34, ,
CD34 Expression as a marker of progression of chronic hepatitis C
BACKGROUND In Egypt, the rate of death/transplantation, decompensation and HCC in patients with compensated HCV cirrhosis is 4.58%, 6.37% and 3.36%, respectively. It is estimated that Egyptian patients with HCV cirrhosis had an annual incidence of HCC with 5.3%. CD34 is a 110-kDa transmembrane glycoprotein present on leukemic cells, endothelial cells and stem cells). CD34 is preferentially expressed on the ... Read more

2018-09-24 18:01:53 Keywords liver, CD34,
CD34 Expression as a marker of progression of chronic hepatitis C
In Egypt, the rate of death/transplantation, decompensation and HCC in patients with compensated HCV cirrhosis is 4.58%, 6.37% and 3.36%, respectively. It is estimated that Egyptian patients with HCV cirrhosis had an annual incidence of HCC with 5.3%. CD34 is a 110-kDa transmembrane glycoprotein present on leukemic cells, endothelial cells and stem cells). CD34 is preferentially expressed on the surface ... Read more

2018-09-28 16:30:01 Keywords CD34, Chronic Hepatitis C,
CD34 Expression as a marker of progression of chronic hepatitis C
In Egypt, the rate of death/transplantation, decompensation and HCC in patients with compensated HCV cirrhosis is 4.58%, 6.37% and 3.36%, respectively. It is estimated that Egyptian patients with HCV cirrhosis had an annual incidence of HCC with 5.3%. CD34 is a 110-kDa transmembrane glycoprotein present on leukemic cells, endothelial cells and stem cells). CD34 is preferentially expressed on the surface ... Read more